article Refreshing how we approach neuroscience with a novel screening technology 9 April 2020 | By Hannah Balfour (Drug Target Review) Drug Target Review discusses how NETSseq, a novel profiling technology, is bringing new insights to neurodegenerative and psychiatric diseases.
news Novel ligands developed with high affinity for Alzheimer’s receptors 7 April 2020 | By Victoria Rees (Drug Target Review) A group of researchers has synthesised a new class of ligands which bind with high affinity to imidazoline I2 receptors, a drug target for Alzheimer's disease.
news BT13 molecule shows promise for halting Parkinson’s 18 February 2020 | By Nikki Withers (Drug Target Review) A molecule has been shown to increase dopamine levels in the brains of mice, offering hope for stopping the progression of Parkinson’s.
news Researchers discover α-synuclein clue to treating Parkinson’s 17 January 2020 | By Victoria Rees (Drug Target Review) A study has shown that fruit fly larvae lacking a certain region of the α-synuclein protein did not exhibit Parkinson’s symptoms, indicating a potential target.
news Screening platform reveals compounds that protect neuronal mitochondria 13 January 2020 | By Victoria Rees (Drug Target Review) Researchers have developed a screening system and identified a set of compounds that protect neuronal mitochondria in mice.
news Exosomes used by researchers as form of novel gene therapy 17 December 2019 | By Victoria Rees (Drug Target Review) A study has demonstrated that exosomes can be used as nanocarriers for therapeutic contents, as a new type of gene therapy.
news Rhomboid protease role observed using dynamic imaging 28 October 2019 | By Rachael Harper (Drug Target Review) Researchers have been able to watch rhomboid proteases in a native lipid environment which may be useful for the development of Parkinson's and malaria medication.
news Neurodegeneration enzyme identified in mouse models 25 June 2019 | By Drug Target Review A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
news Molecule which targets Parkinson’s protein identified 6 June 2019 | By Victoria Rees (Drug Target Review) A new study has identified a molecule which targets a protein linked with Parkinson’s.
news Compounds in coffee may fight Parkinson’s 11 December 2018 | By Drug Target Review Caffeine plus another compound in coffee beans' waxy coating may protect against brain degeneration...
news Ageing hallmark in neurons discovered by biologists 27 November 2018 | By Drug Target Review Oxidative stress occuring in neurons produces unusual piles of short snippets of RNA and could be a marker of neurodegenerative diseases...
news Inhibiting USP13 destroys toxic clumps seen in Parkinson’s disease 14 November 2018 | By Drug Target Review A team of neurologists have found that one reason Lewy bodies develop is that a molecule, USP13, has removed all the "tags" placed on alpha-synuclein that mark the protein for destruction...
news Better drug delivery through the blood-brain barrier 19 October 2018 | By Iqra Farooq (Drug Target Review) Drug delivery through the blood-brain barrier has shown to be difficult to overcome, but researchers may have discovered a method to overcome this issue...
news Laser-capture RNA seq technique connects Parkinson’s and psychiatric diseases 21 September 2018 | By Drug Target Review A comprehensive study reveals an expanding universe of 'darkest of the dark matter' RNAs in dopamine-producing cells in our brains...
news The molecular link between ageing and neurodegeneration 28 August 2018 | By Drug Target Review Researchers have described the discovery of a molecular link between ageing and a major genetic cause of both ALS and FTD...